General MedicationsNASALGeneric
FLUNISOLIDE
FLUNISOLIDE
Standard Dose
0.029MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview FLUNISOLIDE is listed in Drugs@FDA under application 077436 (ANDA).
Marketing status: Discontinued Active ingredient FLUNISOLIDE Form and strength SPRAY, METERED;NASAL - 0.029MG/SPRAY Sponsor APOTEX Submission history Latest submission status date: 2007-08-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview FLUNISOLIDE is listed in Drugs@FDA under application 077436 (ANDA). Marketing status: Discontinued Active ingredient FLUNISOLIDE Form and strength SPRAY, METERED;NASAL - 0.029MG/SPRAY Sponsor APOTEX Submission history Latest submission status date: 2007-08-09 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.